Clinical Trial Update: A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating BPM31510 with Vitamin K1 in newly diagnosed glioblastoma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• BPM31510 (BPM31510)
• VITAMIN K1 (PHYTONADIONE)

Snippet

Sponsor: BPGbio | Conditions: Glioblastoma, Glioblastoma Multiforme | Phase 2 | Status: ACTIVE_NOT_RECRUITING